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Meeting risk with resilience: high daily life
reward experience preserves mental health
Introduction
The foolishman seeks happiness in the distance, the
wise grows it under his feet (James Oppenheim).
This quote refers to the ability to enjoy the moment
instead of living in the future. Some people are able
to generate an abundance of positive emotions from
pleasant everyday events like going to a birthday
party, seeing an inspiringmovie or eating tasty food.
In other words, they have the ability to use pleasant
events to boost their mood, at least temporarily, be
it deliberate or non-deliberate. Does this ability
make them more resilient in the long run? Here we
examine prospectively whether the ability to gener-
Geschwind N, Peeters F, Jacobs N, Delespaul P, Derom C, Thiery E,
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Objective: To examine prospectively whether high reward experience
(the ability to generate positive affect boosts from pleasurable daily
events) protects against affective symptoms and whether environmental
or genetic risk factors moderate protective effects.
Method: At baseline, 498 female twins participated in an experience
sampling study measuring reward experience in daily life. They also
completed questionnaires on childhood adversity and recent stressful
life events (SLE). Affective symptoms were measured at baseline and at
four follow-ups using SCL-90 anxiety and depression subscales.
Co-twin affective symptoms were used as indicators of genetic risk.
Results: Baseline reward experience did not predict follow-up affective
symptoms, regardless of level of genetic risk. However, high reward
experience was associated with reduced future affective symptoms after
previous exposure to childhood adversity or recent SLE.
Conclusion: High daily life reward experience increases resilience after
environmental adversity; modification of reward experience may
constitute a novel area of therapeutic intervention.
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Significant outcomes
• The ability to generate positive affect boosts (reward experience) from pleasant daily life events
preserves mental health, but only in case of high childhood adversity or recent stressful life events.
• High daily life reward experience may thus represent a mechanism of resilience in people at risk for
depression and related disorders.
• Novel treatments for the prevention of affective disorders should focus on enhancing daily life
reward experience in people who experienced early or late environmental adversity. Discovering how
to enhance reward experience remains a challenge for future research.
Limitations
• The observations of the experience sampling data rely on participants compliance.
• Childhood trauma and recent stressful life events were measured retrospectively.
• Because participants were female only, the results may not be generalizable to men.
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ate boosts in positive affect (PA) in response to
pleasurable daily life events is associated with more
favourable mental health outcomes.
In general, PA is a strong candidate for resilience
against stress-related disorders, because it reduces
stress-induced psychiatric and physiological symp-
toms (1–5). In daily life, experiencing PA during
moments of minor daily life stress is associated
with lowered sensitivity to stress. In other words,
the usual increase in negative affect (NA) (in
reaction to stressful events) is less pronounced
when people experience PA (6). Furthermore,
Fredrickson and colleagues recently found that
experiencing more PA predicted increased personal
resources (like social support and purpose in life),
which in turn predicted decreased affective symp-
toms (4). Similarly, a retrospective study showed
that maintaining near-normal levels of positive
emotions during the aftermath of the September 11
terrorist attacks was associated with less affective
symptoms a couple of weeks later (7). These studies
show that PA buffers the effects of stressful events.
Apart from that, PA also reduces the expression
of genetic vulnerability for affective disorders.
Individuals with genetic vulnerability for depres-
sion are more stress sensitive than individuals
without genetic vulnerability (8). However, in
situations of high PA, the difference in stress
sensitivity between genetically vulnerable and non-
vulnerable individuals is reduced (6). A study using
direct genetic information found similar results:
experiencing positive emotions neutralizes the dif-
ference in stress sensitivity caused by the BDNF
val66met genotype (9).
Thus, the existing literature demonstrates that PA
preserves, and possibly improves, mental health.
Preserving mental health becomes particularly
important in the presence of environmental or
genetic risk. Childhood adversity (10, 11) as well as
recent stressful life events (SLE) (12–14) are impor-
tant environmental risk factors, because they
increase daily life stress sensitivity as well as the risk
for major depression and related disorders (15, 16).
Given the many benefits of PA, we expect that the
ability to generate boosts in PA from pleasant daily
life situations (hereafter: high reward experience) will
contribute to the preservation of mental health. We
predict that high reward experience, measured at
baseline, will predict low affective symptoms at
follow-up, especially when someone is at risk for low
mood (due to either environmental adversity like
childhood adversity or recent SLE or genetic risk),
see Fig. 1. We tested these hypotheses in a prospec-
tive twin study, using the experience sampling
method (ESM). ESM is optimally equipped to test
these hypotheses, because it measures peoples
experiences in their own daily life context, not only
prospectively but also repetitively, catching vari-
ability in the flow of daily life. This type of
measurement is necessary to reliably capture such
a dynamic concept as daily life reward experience.
Aims of the study
The aims of our study are to examine prospectively
whether high reward experience (the ability to
generate positive affect boosts from pleasant
events) contributes to resilience against affective
disorders, and how this protective effect is moder-
ated by environmental and genetic risk factors.
Material and methods
Sample
The study sample consisted of 621 female partic-



















Fig. 1. Daily life reward experience and expected relations
with follow-up affective symptoms. People with high reward
experience are able to generate stronger positive affect (PA)
boosts in response to pleasant events than people with low
reward experience. Higher daily life reward experience is
hypothesized to be associated with less follow-up affective
symptoms, especially in people at risk for affective symptoms,
i.e. those with higher levels of childhood trauma, recent
stressful life events (SLE) and genetic risk.
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participants were general population twin pairs
and 46 of their non-twin sisters. Two-hundred and
eighteen of these twin pairs were recruited from the
East-Flanders Prospective Twin Survey (EFPTS),
which has prospectively recorded all multiple
births in the province of East-Flanders since 1964
(17, 18). Twin zygosity was determined at birth for
EFPTS participants. For the other participants,
zygosity was determined through a sequential
analysis based on sex, foetal membranes, blood
groups, DNA fingerprints, and interviews (19). The
study was approved by the Ethics Committee of
Maastricht University, and all participants pro-
vided written informed consent.
Experience sampling method
Experience sampling method is a structured diary
technique to assess participants in their daily living
environment. ESM has been validated for the use
of studying the immediate effects of daily life
situations on mood (20–23). Participants received a
digital wristwatch and a set of ESM self-assess-
ment forms collated in a booklet for each day. The
wristwatch was programmed to emit a signal
(beep) at an unpredictable moment in each of
ten 90-min time blocks between 7:30 and 22:30, on
five consecutive days, resulting in a maximum of 50
beeps per person. After each beep, participants
were asked to stop their activity and fill out the
ESM self-assessment forms, with regard to
thoughts, mood, current context (activity, persons
present and location) and appraisals of current
situation and, finally, the most important event
since the last beep. All self-assessments were rated
on 7-point Likert scales. Trained research assis-
tants with ample experience in momentary assess-
ment techniques explained the ESM procedure to
the participants during an initial briefing session,
and participants completed an ESM practice form
to confirm that they understood the 7-point Likert
scale. Participants could call a telephone number in
case they had questions or problems during the
ESM sampling period. Participants were told to
complete their reports immediately after the beep,
thus minimizing memory distortion, and to record
the time at which they completed the form. In
order to know whether the participants had
completed the form within 15 min of the beep,
the time at which participants indicated they
completed the report was compared to the actual
time of the beep. All reports not filled in within
15 min after the beep were excluded from the
analysis, since previous work (22) has shown that
reports completed after this interval are less
reliable and consequently less valid. In addition,
previous work has shown that participants who
have valid reports for at least one-third of all
measurements can be included since their missing
data does not distort the results, whereas measures
of individuals with fewer than 30% of completed
reports are less reliable (22). Therefore, partici-
pants with fewer than 17 valid reports (out of 50)
were excluded from the analysis.
Design
Participants were assessed at baseline (ESM,
childhood adversity, recent SLE and affective
symptoms) and at four follow-up time points
(affective symptoms). The average number of
days between baseline and first follow-up was
132, between first and second follow-up 91,
between second and third follow-up 116 and
between third and fourth follow-up 91.
Measurements
Affective symptoms. Participants completed the
Symptom Checklist (SCL-90R) (24, 25) at baseline
and at four follow-up assessments. The SCL-90R is
a comprehensive self-report symptom inventory,
multidimensional in nature and oriented to screen
for a broad range of psychological problems and
psychopathology in community respondents. It
contains 90 items, scored on a 5-point severity
scale, measuring nine primary symptom dimen-
sions named Somatization, Obsessive-Compul-
sive, Interpersonal Sensitivity, Depression,
Anxiety, Hostility, Phobic Anxiety, Paranoid
Ideation and Psychoticism.
Per participant, SCL-90R depression and anxi-
ety scales were averaged for each measurement
occasion, resulting in a combined score reflecting
affective symptoms.
Childhood adversity. Childhood adversity was
measured using the shortened version (26) of the
70-item Childhood Trauma Questionnaire [Jeugd
Trauma Vragenlijst (Dutch version), A. Arntz and
I. Wessel, unpublished data; 27]. At the request of
the Twin Registry, the most explicit items concern-
ing sexual and physical abuse were omitted; less
explicit items were retained. The questionnaire thus
consisted of 21 items with statements concerning
early life experiences, such as I was abused, There
was not enough food and I was neglected. Items
were scored on a scale of 1 (never true) to 5 (very
often true). Cronbachs alpha for this 21-item
questionnaire was 0.93. The sum score of all items
was used as a continuous measure of childhood
adversity.
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Recent stressful life events. Our inventory of recent
SLE was based on the event list of the interview for
recent life events (28). Participants reported
whether any of 61 events happened in the past
6 months and indicated how unpleasant the expe-
rience was to them (from 1 = very pleasant to
5 = very unpleasant). SLE were divided into 10
categories: work, education, finance, health,
bereavement, migration, courtship and cohabita-
tion, legal, family and social relationships, and
marital relationships, all representing datable
occurrences involving changes in the external
social environment. Only SLE rated as unpleasant
(i.e. with a score of 4, unpleasant, or a score of 5,
very unpleasant) were included in the analysis.
The number of such unpleasant events in the past
6 months was used as a continuous measure of
recent SLE (19).
Genetic risk for affective symptoms. Genetic risk for
affective symptoms was assessed indirectly using
information on the affective health of the co-twin.
The continuous variable co-twin affective symp-
toms was constructed, representing baseline affec-
tive symptoms of the participants co-twin. To
obtain an indicator of genetic risk for depression,
this variable was paired with information about
twin zygosity (mono- or dizygotic).
Daily life events, affect and reward experience. Mea-
sures of daily life events and affect were extracted
from the ESM framework, participants rated their
current mood on 7-point Likert scales ranging
from 0 (not at all) to 7 (very much). The mean of
the PA items (I feel cheerful, content, energetic
and enthusiastic) formed the PA scale (Cron-
bachs alpha = 0.86 over the participant mean).
Negative affect was assessed with six mood adjec-
tives (I feel insecure, lonely, anxious, low,
guilty and suspicious) and had a Cronbachs
alpha = 0.76 over the participant mean. After
rating their affect, participants reported the most
important event that happened between the current
and the previous beep and rated that event on a
7-point bipolar scale ()3 = very unpleasant,
0 = neutral, 3 = very pleasant). Reward experi-
ence was conceptualized as the effect of pleasant
daily life events (i.e. only those events rated as 0
(neutral) to 3 (very pleasant)) on PA (29). For
each participant reporting at least four pleasant
events, a reward experience variable was con-
structed by regressing beep-moment PA on the
pleasantness score of the most recently reported
daily life event (29). This variable thus reflects the
extent to which the pleasantness of daily life events
translates into increases in PA, see Fig. 1. Some
people, for example, experience just a small
increase in PA after an event they rated as very
pleasant, say a birthday party. Others experience a
much larger increase in PA, suggesting that they
can use the birthday party more effectively to
generate positive emotions. Stress sensitivity was
conceptualized likewise as NA reactivity to
unpleasant daily life events, see (8).
Analysis
This study consisted of five measurement occasions.
Most of the participants were twins. This means
that the data were clustered: the five measurement
occasions were clustered within participants, who
were clustered in twin pairs. Clustering induces
correlation in the data: measurements within par-
ticipants are more alike than measurements
between participants, and measurements within
twin pairs are more alike than measurements
between twin pairs. Appropriate analysis tech-
niques are necessary to handle the correlations
induced by the clustered data (30). We used the
STATA XTMIXED multilevel linear regression
command.
All analyses were corrected for baseline SCL-
90R affective symptoms to ensure that associations
between follow-up affective symptoms and baseline
variables reflected effects on change in affective
symptoms. All variables included in the analyses
were standardized, yielding standardized effect
sizes.
To examine our hypotheses, we ran the follow-
ing regression analyses: the main effect of reward
experience on follow-up affective symptoms was
examined by regressing affective symptoms on
reward experience. Regarding the hypothesis that
risk factors moderate the effect of reward experi-
ence on affective symptoms, follow-up affective
symptoms were regressed on the interaction
between the risk factor and reward experience.
This was done separately for each of the three risk
factors (childhood adversity, recent SLE and
genetic risk). For childhood adversity and recent
SLE, this resulted in regressions with a two-way
interaction (childhood adversity · reward experi-
ence ⁄ recent SLE · reward experience). Significant
interactions were followed up by dose–response
analyses. Dose–response relationships were exam-
ined by dividing the distribution of values for
childhood adversity and recent SLEs by their
tertiles using the STATA XTILE command. The
STATA LINCOM command was used subse-
quently to calculate effect sizes of the differences
between the low risk group and the medium
or high risk group respectively. For genetic risk,
Geschwind et al.
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the regression contained a three-way interaction
(co-twin affective symptoms · zygosity · reward
experience). The STATA LINCOM command
was used to calculate stratified effect sizes for
mono- and dizygotic twins.
When risk factors were significantly associated
with each other, the independence of their effects
was checked by simultaneously entering their
interactions (with reward experience) into the
regression model.
Finally, the analyses were repeated to correct for
a number of potential confounders. First, it is
known that stress sensitivity influences risk for
affective symptoms (8). To ensure that possible
protective effects of high reward experience were
not an artefact of low stress sensitivity, all analyses
were repeated whilst correcting for stress sensitiv-
ity. Second, all analyses were repeated excluding
the 20 participants who were depressed at baseline,
to verify that the retrospective measures of child-
hood adversity and recent SLE were not contam-
inated by current depression status. Third, all
analyses were re-run whilst additionally correcting
for the number of positive events experienced by




Of the total sample of 621 participants, 610
participated in the ESM procedure. Thirty-one
participants were excluded because they had fewer
than 17 valid ESM self-reports. Another 81
participants were excluded due to missing data on
either i) affective symptoms at all follow-ups, ii)
baseline reward experience or iii) baseline affective
symptoms. This resulted in a dataset of 498
participants that were part of 246 different twin
pairs. Of the 498 participants, 286 were mono-
zygotic twins, 170 were dizygotic twins, two were
twins of unknown zygosity, and 40 were non-twin
sisters of twins. For the analysis on genetic risk,
non-twin sisters and twin-pairs of unknown
zygosity were excluded. Of the remaining twins,
13 had missing data on co-twin affective symp-
toms, leaving 443 participants (280 monozygotic
and 163 dizygotic twins) in the analyses involving
genetic risk. Five of the 498 participants had
missing data on childhood adversity, leaving 493
participants in the analyses involving childhood
adversity. Mean age of the 498 participants was
28 years (SD: 7.9 years, range: 18–61). Sixty-five
per cent had a college or university degree, 33%
completed secondary education and 1% had
primary education only. The majority was cur-
rently employed (60% employed, 31% student,
2% unemployed, 3% homemaker and 1% sick
leave). Ninety-seven per cent participated in at
least two, 91% in at least three and 79% in all
four follow-ups.
Multilevel analyses showed no significant associ-
ation between reward experience on the one hand
and genetic risk [b = )0.15, v2(1) = 2.84, P =
0.11], childhood adversity (b = 0.08, P = 0.09)
and recent SLE [b = 0.03, v2(1) = 0.50,P = 0.48]
on the other. Childhood adversity was significantly
associated with later experience of SLE [b = 0.21,
v2(1) = 40.38, P = 0.00]. Therefore, the indepen-
dence of their interaction terms was tested (see
Independence of moderation later on). Other risk
factors were not associated with each other. Mean
score of affective symptomswas 1.47 (SD = 0.50) at
baseline and 1.42 (SD = 0.48) at follow-up assess-
ments. Mean score of childhood adversity was 1.64
(SD = 0.55), andmean score of recent SLE was 2.1
(SD = 2.3).
Associations between reward experience and future affective
symptoms
Main effect. There was no overall association
between reward experience and later affective
symptoms [b = 0.02, v2(1) = 0.49, P = 0.49].
Moderation by childhood adversity. The two-way
interaction between childhood adversity and
reward experience in the model of affective symp-
toms was significant [b = )0.07, v2(1) = 6.05,
P = 0.01]: after childhood adversity, high reward
experience was associated with less future affective
symptoms. A dose–response association was
apparent in that the effect of reward experience
on future affective symptoms became stronger with
higher levels of childhood adversity [average com-
pared to low childhood adversity: b = )0.06,
v2(1) = 0.85, P = 0.36; high compared to low
childhood adversity: b = )0.15, v2(1) = 4.65,
P = 0.03]. For effect sizes of baseline daily
reward experience on follow-up affective symp-
toms, stratified by degree of childhood adversity,
see Fig. 2. Descriptive information on the average
levels of affective symptoms for high and low levels
of reward experience per tertile of childhood
adversity is presented in Table 1.
Moderation by recent stressful life events. As
hypothesized, the two-way interaction between
recent SLE and reward experience was significant
[b = )0.08, v2(1) = 4.65, P = 0.01]. High reward
experience was associated with less future affective
Meeting risk with resilience
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symptoms after recent SLE. There was no linear
dose–response relationship: reward experience was
only associated with future affective symptoms in
participants with a high amount of recent SLE,
compared to those with a low amount [b = )0.21,
v2(1) = 7.99, P = 0.01]. A moderate amount of
recent SLE was not associated with an increase in
the effect of reward experience on follow-up
affective symptoms [b = 0.07, v2(1) = 0.63, P =
0.43]. For effect sizes of baseline reward experience
on follow-up affective symptoms, stratified by level
of recent SLE, see Fig. 2. For descriptive informa-
tion on the average levels of affective symptoms for
high and low levels of reward experience per tertile
of recent SLE, see Table 1.
Moderation by genetic risk. The three-way interac-
tion between affective symptoms in the co-twin,
zygosity and reward experience in the model of
follow-up affective symptoms in the participant
was not statistically significant [b = 0.14,
v2(1) = 0.90, P = 0.34]. However, the two-way
interaction between reward experience and co-
twin affective symptoms on follow-up affective
symptoms was larger in monozygotic twins
(b = )0.20, P = 0.03) than in dizygotic twins
(dizygotic twins: b = )0.06, P = 0.61). This
means that the relationship between high reward
experience and less future affective symptoms
appears to be more pronounced in monozygotic
twins with a symptomatic co-twin than in dizy-
gotic twins with a symptomatic co-twin, suggest-
ing genetic moderation. The difference between
mono- and dizygotic twins, however, is not
significant.
Independence of moderation by childhood adversity and
recent stressful life events. To examine to what
extent the significantly associated risk factors
childhood adversity and recent SLE were indepen-
dent, affective symptoms were regressed on both
two-way interactions (childhood adversity ·
reward experience, recent SLE · reward experi-
ence) simultaneously. The effect size of childhood
adversity · reward experience was reduced by
24%, and the effect size of recent SLE · reward
experience was reduced by 38%. Both interaction
terms were no longer significant.
Results of all analyses remained similar when
additionally controlled for daily life stress sensitiv-
ity or when participants who were depressed at
baseline (n = 20) were excluded from the analyses.
Correcting for the average number of positive
events per participant and for participants average
PA did not influence our results, either.
Discussion
Findings
We hypothesized that high daily life reward expe-
rience increases resilience against follow-up affec-
tive symptoms, and that this association is stronger
in the presence of environmental adversity or
genetic liability. In disagreement with the original
hypothesis, there was no main protective effect of
reward experience on follow-up affective symp-
toms. However, in line with our hypothesis, high
reward experience was indeed associated with low
follow-up affective symptoms in participants
reporting childhood adversity or recent SLE. For
childhood adversity, there was a dose–response
association: with increasing levels of childhood
adversity, the protective effect of high reward
experience became more pronounced. For recent
SLE, the protective effect of high reward experi-




















Fig. 2. Effect of reward experience on follow-up affective
symptoms, stratified by level of environmental adversity
(childhood adversity and recent SLE respectively). A negative
effect size indicates a protective effect. Note: * represents a
statistically significant difference compared to the low risk
group.
Table 1. Means (SD) of affective symptoms by tertiles of childhood adversity and







Low 1.25 (0.26) 1.30 (0.30)
Medium 1.44 (0.40) 1.36 (0.33)
High 1.62 (0.55) 1.54 (0.49)
Recent stressful life events
Low 1.35 (0.34) 1.35 (0.36)
Medium 1.36 (0.34) 1.50 (0.47)
High 1.60 (0.57) 1.43 (0.37)
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highest number of recent SLE. Reward experience
thus becomes more important in the context of
increased vulnerability. The fact that people who
were not or minimally exposed to environmental
adversity do not need extra protection against the
development of affective symptoms makes sense,
since they are not likely to develop symptoms in
the first place.
The experience of childhood adversity increased
the likelihood of recent SLE, which is a phenom-
enon known from other studies (31, 32). Although
both childhood adversity and recent SLE did not
contribute significantly after correcting one for the
other, the effect of childhood adversity remained
more stable than that of adult SLE. This suggests
that early experiences may create an enduring
liability that can be counteracted by resilience
factors.
The three-way interaction reflecting our overall
measure of genetic risk (co-twin affective symp-
toms · zygosity · reward experience) was not sig-
nificant. This may reflect low statistical power,
given the fact that three-way interactions are power
consuming. Effect sizes of reward experience,
however, were associated in a dose–response fash-
ion with level of genetic risk: high reward experi-
ence protected stronger against follow-up affective
symptoms in mono- than in dizygotic twins with
high-symptomatic co-twins. This is in accordance
with the finding above that especially those indi-
viduals at increased risk of developing symptoms
benefit from the ability to effectively generate PA
in daily life. Nevertheless, new studies with more
statistical power are needed to assess whether high
reward experience can indeed increase resilience for
people with high genetic risk for low mood.
Additional analyses showed that the protective
effects of high reward experience were independent
of daily life stress sensitivity (negative affective
reactivity to unpleasant daily life events), indicat-
ing that these represent two separate emotional
pathways. Thus, reward experience, as shown
previously (6) as well as in the current study,
appears to be involved mainly in the development
of resilience whereas stress sensitivity may play a
role in the development of vulnerability (8, 16).
Furthermore, the results were unchanged by the
exclusion of participants who were depressed at
baseline, indicating that their depression status did
not distort the results.
Results also remained similar to the original
analyses when correcting for the amount of pleas-
ant events per participant and average PA per
participant, indicating that PA boosts from pleas-
ant daily life events contribute to resilience inde-
pendently from experiencing PA in general or from
encountering pleasant events. In other words, the
increase in PA after pleasant events appears to be
important apart from overall PA and apart from
the mere frequency of pleasant events.
Taken together, our findings indicate that the
ability to generate PA boosts from pleasant daily
life events increases resilience against affective
symptoms in people with a history of early or
late environmental adversity.
Implications
Individual variation in the ability to generate PA
boosts from pleasant daily events may explain
significant variation in resilience against stress-
related affective disorders. Our findings are in line
with a recent study of Cohn and colleagues (33),
who found that high levels of daily PA predicted
increases in trait resilience. The study of PA is
therefore worthy of greater attention, complement-
ing the main focus on NA. Focussing on PA
should lead to novel treatment approaches and
urgently needed prevention strategies against
increasing numbers of stress-related disorders like
depression. A recent study showed that increases in
reward experience predicted recovery from depres-
sion (34). This implies that the ability to generate
PA boosts from pleasant daily life events can
change. With regard to the timely question of
which groups should be targeted for prevention
(35), our study suggests that efforts to prevent
affective disorders should be aimed at people
exposed to environmental risk factors like child-
hood adversity or recent SLE.
Regarding our concept of reward experience, a
number of open questions remain: First of all,
because of a delay of, on average, 90 min between
consecutive beeps, there can be relatively long time
delays between the recorded pleasant event and
participants report of PA. Therefore, high reward
experience in our study may also have been a
question of being more capable of maintaining PA,
once activated, rather than letting it dissipate to a
minimal, base level. More research is needed in
order to find out exactly what constitutes the
protective component in reward experience – the
ability to generate PA efficiently, or the ability to
maintain it for longer. Furthermore, because cur-
rent PA was rated at the same time as pleasantness
of the most important event since the last beep,
beep-moment mood may have influenced ratings of
event pleasantness, rather than the pleasantness of
the most important event influencing mood. Future
research should try to disentangle these effects,
maybe by separating those questions into different
beeps. A third question is whether – and how – the
Meeting risk with resilience
135
ability to experience reward from everyday events
can be enhanced. Both pharmacological as well as
non-pharmacological approaches are possible.
Pharmacological approaches to enhancing reward
experience. Knowledge about the biological mech-
anisms of reward experience is important for
discovering new ways to enhance resilience. Studies
suggest that dopamine projections to the prefrontal
cortex are involved in the conscious experience of
reward (36–39). The COMT enzyme, which breaks
down dopamine, is closely involved in dopamine
regulation in the prefrontal cortex (40, 41). Lower
levels of COMT lead to higher prefrontal dopa-
mine levels, and should therefore be associated
with a higher ability to experience reward.
Indeed, a recent experience sampling study
found that daily life reward experience increased
proportionally with the number of Met alleles on
the COMT Val158Met polymorphism (29). The
Met allele is associated with lower COMT activity,
and, as a result, higher levels of prefrontal dopa-
mine than the Val allele (42). Participants with the
Met ⁄Met genotype generated comparable levels of
reward experience from events rated as a bit
pleasant as participants with the Val ⁄Val genotype
generated from events rated as very pleasant (29).
Similarly, participants with the Met ⁄Met genotype
had the highest prefrontal responses to anticipated
and delivered rewards in a recent neuroimaging
study (43), again indicating that individuals with
Met allele experience more reward than individuals
with the Val allele.
In sum, the available evidence suggests that
biological agents acting on dopamine pathways
might be successful in enhancing the ability to
experience reward. Although many antidepressants
target the dopaminergic system (44), it is still
unclear to what extent antidepressants improve
reward experience. One recent study using imipra-
mine (34) suggests that response to antidepressants
is mediated at least in part by changes in reward
experience. However, further research is necessary
to find out to what extent pharmacological inter-
ventions can improve reward experience.
Non-pharmacological approaches to enhancing reward
experience. The fact that biological factors par-
tially underlie reward experience does not exclude
the possibility that non-pharmacological interven-
tions are effective in modifying reward experience.
For example, Goldapple and colleagues demon-
strated that cognitive-behavioural therapy led to
changes in cortical-limbic pathways in depressed
patients (45), and Davidson and colleagues (46)
found that an 8-week mindfulness meditation
program resulted in increases in activation in the
left anterior hemisphere, which is associated with
the experience of PA (47, 48). Furthermore, many
patients prefer non-pharmacological treatment
over taking medication (49).
Research suggests that meditation-based tech-
niques, such as mindfulness-based cognitive ther-
apy, might be an alternative way to enhance daily
life reward experience. Participation in a 7-week
meditation workshop led to significant increases in
PA in a non-clinical sample (4). Furthermore, more
advanced meditators experienced more PA than
less advanced meditators (50), and participants
reported more PA when in a mindful compared to
a non-mindful state (51).
During mindfulness training sessions, partici-
pants are trained towards increased moment-
to-moment awareness of experience, resulting in
increased openness or receptiveness (52). An
enhanced receptiveness might improve the ability
to make use of natural daily life rewards. However,
these suggestions remain speculative. Discovering
to what extent – and how – daily life reward
experience can be enhanced therefore remains a
challenging task for future research.
Strengths
Strengths of the study include the use of the ESM
to establish a measure of reward experience in daily
life. In contrast to conventional questionnaires or
interviews, ESM measurements are prospective,
repeated and cover only a short and recent time
span, thereby decreasing memory bias (22). Fur-
thermore, ESM provides sensitive information on
the dynamic relationship between the emotional
responses of an individual and his or her daily life
context.
A second strength is the studys longitudinal
design, with affective symptoms being measured at
baseline and at four follow-up time points.
Finally, genetic risk was estimated sensitively by
combining zygosity with a continuous measure of
affective symptoms in the co-twin.
Limitations
First, it has been suggested that problems may
arise in the ESM procedure, as it depends on
participants compliance (53). In particular fixed
time sampling protocols may be problematic and
can bias results. However, this report did not use a
fixed-time sampling frame, and our ESM proce-
dure was validated in a previous report that used
electronic monitoring devices. Results showed that
compliance was high (over 90%) and inclusion of
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the inaccurately timed reports did not distort the
data (54).
Second, reward experience was assessed pro-
spectively but contained a cross-sectional element
as the relationship between PA and pleasantness of
most important event (since the last beep) was
assessed at each ESM moment. Therefore, it is
possible that participants matched their recall of
the event to their mood at the moment of the beep,
rather than, pleasantness of the most important
event influencing mood. However, either explana-
tion bears clinical relevance, and the interpretation
that pleasant events contribute to PA undoubtedly
has face validity.
Third, childhood adversity and recent negative
life events were measured retrospectively and
through self-report. It is possible that those self-
report measures were influenced by current mood
state. However, all analyses were controlled for
baseline affective symptoms, making it unlikely
that results of the current study are the conse-
quence of confounding by mood state. Moreover,
the childhood trauma questionnaire has been
found to have high test–retest reliability as well
as good convergence with other (i.e. interview)
forms of administration (27), and the interview for
recent life events was designed specifically to collect
datable occurrences involving changes in the
external social environment rather than internal
occurrences (28).
A fourth limitation is that the sample was female
only. Consequently, our findings cannot be gener-
alized to the male population. Furthermore, par-
ticipants were mainly of middle age and, on
average, higher educated than the general Belgium
population.
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